Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors
post
Last Updated on: 22 November, 2024
Author: Getaka|Social: Getaka Financial Services X (Earlier Twitter) Profile Getaka Financial Services LinkedIn Logo
Stock Ticker - BSE: 500459 | NSE: PGHH

Procter & Gamble Hygiene and Health Care Ltd: Intrinsic Value and Fundamental Analysis

Share Price and Basic Stock Data

Last Updated: November 21, 2024, 10:36 pm

Market Cap 51,525 Cr.
Current Price 15,876
High / Low18,250/15,306
Stock P/E76.2
Book Value 239
Dividend Yield1.23 %
ROCE112 %
ROE78.9 %
Face Value 10.0
PEG Ratio6.65

Stock P/E, Current Price, and Intrinsic Value Over Time

View Share Price Target for Procter & Gamble Hygiene and Health Care Ltd

Competitors of Procter & Gamble Hygiene and Health Care Ltd

Stock NameMarket CapCurrent PriceHigh / LowStock P/EBook ValueDividend YieldROCEROEFace Value
Honasa Consumer Ltd 7,731 Cr. 238547/237102 35.50.00 %17.1 %% 10.0
Ambica Agarbathies Aroma & Industries Ltd 51.2 Cr. 29.943.2/23.234.2 60.60.00 %5.07 %3.65 % 10.0
Ador Multi Products Ltd 15.1 Cr. 32.345.9/30.1 23.20.00 %33.6 %26.7 % 10.0
Kaya Ltd 460 Cr. 348702/267 1060.00 %80.4 %% 10.0
Jyothy Labs Ltd 14,885 Cr. 405596/36739.6 51.40.86 %27.0 %21.2 % 1.00
Industry Average72,450.14 Cr2,175.3453.02103.770.70%36.77%29.68%4.94

All Competitor Stocks of Procter & Gamble Hygiene and Health Care Ltd

Quarterly Result

MonthJun 2021Sep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Sales7871,0581,0939737761,0451,1378838531,1381,1331,002932
Expenses712757797808709831847734638853824745813
Operating Profit7530129616567214290149215285310257118
OPM %10%28%27%17%9%20%26%17%25%25%27%26%13%
Other Income667667914101616147
Interest1137114432322-0
Depreciation13131313141414151514141513
Profit before tax6729428815158206282146207284309234112
Tax %27%26%26%32%26%25%26%-13%27%26%26%34%28%
Net Profit492182121034315420716515121122915481
EPS in Rs15.0967.2565.3331.6813.1147.5763.9150.8446.5964.9170.5247.5624.97

Last Updated: Unknown

Quarterly Chart

Profit & Loss - Annual Report

Last Updated: Unknown

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023TTM
Sales1,2971,6772,0512,3342,2752,3202,4552,9473,0023,5743,9013,9184,126
Expenses1,0971,4201,6281,8381,6671,6461,8342,3292,3962,6883,0693,0483,060
Operating Profit2012564234956086756226186068868328691,067
OPM %15%15%21%21%27%29%25%21%20%25%21%22%26%
Other Income51617864856718454238234055
Interest00566105566111130
Depreciation28313553526052504848535859
Profit before tax2232864605016366725826075948707908391,034
Tax %19%29%34%31%34%36%36%31%27%25%27%19%
Net Profit181203302346422433375419433652576678745
EPS in Rs55.8562.6093.04106.63130.16133.31115.40129.12133.42200.79177.37208.91229.58
Dividend Payout %40%40%30%28%28%292%35%68%79%157%90%89%

Profit & Loss Yearly Chart

YoY Net Profit Growth

Year
YoY Net Profit Growth (%)
Change in YoY Net Profit Growth (%)

No data available for trend analysis.

Growth

Compounded Sales Growth
10 Years:7%
5 Years:7%
3 Years:6%
TTM:5%
Compounded Profit Growth
10 Years:8%
5 Years:10%
3 Years:1%
TTM:-8%
Stock Price CAGR
10 Years:11%
5 Years:8%
3 Years:1%
1 Year:-11%
Return on Equity
10 Years:53%
5 Years:69%
3 Years:80%
Last Year:79%

Last Updated: Unknown

Balance Sheet

Last Updated: September 15, 2024, 4:13 pm

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Equity Capital323232323232323232323232
Reserves7739701,1961,6194947738771,125682705914742
Borrowings000000003543
Other Liabilities4445057195156346207086719159401,1871,081
Total Liabilities1,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,859
Fixed Assets215240309317286250234206184164170139
CWIP419839354121152238442328
Investments000000000000
Other Assets9931,1701,6001,8148341,1541,3681,6001,4111,4751,9451,692
Total Assets1,2491,5081,9482,1661,1601,4251,6171,8281,6331,6832,1371,859

Reserves and Borrowings Chart

Cash Flow

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Cash from Operating Activity +104335426352445415413474863573826471
Cash from Investing Activity +-31-13528221149-1934757-27-101
Cash from Financing Activity +-85-95-105-122-1,559-106-314-190-1,106-569-477-862
Net Cash Flow-12105349452-964290134358-236-23339-390

Free Cash Flow

MonthJun 2012Jun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023
Free Cash Flow201.00256.00423.00495.00608.00675.00622.00618.00606.00883.00827.00865.00

Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)

Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.

Free Cash Flow Chart

Financial Efficiency Indicators

MonthJun 2013Jun 2014Jun 2015Jun 2016Jun 2017Jun 2018Jun 2019Jun 2020Jun 2021Jun 2022Jun 2023Jun 2024
Debtor Days181518242122222015182021
Inventory Days625347537148606878554851
Days Payable106103148134145156162175237183213193
Cash Conversion Cycle-27-35-83-57-53-87-79-87-144-110-145-121
Working Capital Days514348-15-23-12-21-38-34-53-32
ROCE %39%52%46%45%64%89%73%58%94%110%101%112%

Financial Efficiency Indicators Chart

Share Holding Pattern

MonthSep 2021Dec 2021Mar 2022Jun 2022Sep 2022Dec 2022Mar 2023Jun 2023Sep 2023Dec 2023Mar 2024Jun 2024
Promoters70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%70.64%
FIIs2.57%2.63%2.25%2.03%1.68%1.12%1.05%1.13%1.30%1.48%1.57%1.56%
DIIs13.48%13.48%13.89%14.19%14.56%15.28%15.44%15.49%15.45%15.29%15.11%15.16%
Public13.31%13.26%13.22%13.14%13.12%12.96%12.87%12.73%12.61%12.60%12.67%12.65%
No. of Shareholders41,12040,90840,81941,53343,44540,49539,96839,38837,06938,80739,99940,671

Shareholding Pattern Chart

No. of Shareholders

Mutual Fund Holdings

Fund NameNo of SharesAUM (%)Amount Invested (Cr)Previous Number of SharesPrevious DatePercentage Change
SBI Focused Equity Fund1,000,0004.741661.3200,0002024-11-20400%
SBI Equity Hybrid Fund430,0001714.36200,0002024-11-20115%
ICICI Prudential Bluechip Fund333,2820.93553.68200,0002024-11-2066.64%
SBI Magnum Global Fund210,0005.22348.87200,0002024-11-205%
SBI Magnum Midcap Fund200,0001.64332.26200,0002024-11-200%
Aditya Birla Sun Life MNC Fund - Div72,4852.99120.42200,0002024-11-20-63.76%
Aditya Birla Sun Life MNC Fund - Gr72,4852.99120.42200,0002024-11-20-63.76%
ICICI Prudential Large & Mid Cap Fund62,4110.72103.68200,0002024-11-20-68.79%
UTI MNC Fund38,0102.0463.15200,0002024-11-20-81%
SBI Consumption Opportunities Fund38,0002.6363.13200,0002024-11-20-81%

ROCE Trend

EPS Trend

Key Financial Ratios

MonthJun 23Jun 22Jun 21Jun 20Jun 19
FaceValue10.0010.0010.0010.0010.00
Basic EPS (Rs.)208.91177.37200.79133.42129.12
Diluted EPS (Rs.)208.91177.37200.79133.42129.12
Cash EPS (Rs.)226.89193.66215.48148.17144.46
Book Value[Excl.RevalReserv]/Share (Rs.)291.44227.22220.05356.70280.06
Book Value[Incl.RevalReserv]/Share (Rs.)291.44227.22220.05356.70280.06
Dividend / Share (Rs.)185.00160.00315.00105.0088.00
Revenue From Operations / Share (Rs.)1206.991201.761101.09924.83907.84
PBDIT / Share (Rs.)280.10263.16284.55199.57204.13
PBIT / Share (Rs.)262.12246.87269.87184.82188.79
PBT / Share (Rs.)258.62243.42267.99182.95187.10
Net Profit / Share (Rs.)208.91177.37200.80133.42129.12
PBDIT Margin (%)23.2021.8925.8421.5722.48
PBIT Margin (%)21.7120.5424.5019.9820.79
PBT Margin (%)21.4220.2524.3319.7820.60
Net Profit Margin (%)17.3014.7518.2314.4214.22
Return on Networth / Equity (%)71.6878.0691.2537.4046.10
Return on Capital Employeed (%)80.8597.31109.8748.6462.88
Return On Assets (%)31.7234.2439.9223.6825.68
Asset Turnover Ratio (%)2.052.352.071.741.93
Current Ratio (X)1.381.321.342.231.66
Quick Ratio (X)1.181.051.041.891.35
Inventory Turnover Ratio (X)3.745.224.975.225.83
Dividend Payout Ratio (NP) (%)69.4098.66169.3235.9761.95
Dividend Payout Ratio (CP) (%)63.9090.36157.7932.3955.37
Earning Retention Ratio (%)30.601.34-69.3264.0338.05
Cash Earning Retention Ratio (%)36.109.64-57.7967.6144.63
Interest Coverage Ratio (X)79.9076.34151.17106.72120.91
Interest Coverage Ratio (Post Tax) (X)60.5952.45107.6872.3577.48
Enterprise Value (Cr.)45454.0942869.0042606.6732060.9534210.09
EV / Net Operating Revenue (X)11.6010.9911.9210.6811.61
EV / EBITDA (X)49.9950.1946.1349.4951.63
MarketCap / Net Operating Revenue (X)11.8511.1512.1110.9811.79
Retention Ratios (%)30.591.33-69.3264.0238.04
Price / BV (X)49.0858.9960.5828.4738.23
Price / Net Operating Revenue (X)11.8511.1512.1110.9811.79
EarningsYield0.010.010.010.010.01

Profitability Ratios (%)

Liquidity Ratios

Liquidity Ratios (%)

Interest Coverage Ratios (%)

Valuation Ratios

Fair Value

Fair Value of Procter & Gamble Hygiene and Health Care Ltd as of November 22, 2024 is: 14,545.85

Calculation basis:

  • Fair value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.

This formula allows us to gauge the fair value of the stock by analyzing its fundamental indicators.

As of November 22, 2024, Procter & Gamble Hygiene and Health Care Ltd is Overvalued by 8.38% compared to the current share price 15,876.00

Intrinsic Value of Procter & Gamble Hygiene and Health Care Ltd as of November 22, 2024 is: 16,213.68

Calculation basis:

  • Intrinsic value = P/E Ratio * (Return on Equity / 100) * Book Value * (1 + Dividend Yield / 100) * (1 + EPS CAGR for Last 5 Years)
  • P/E Ratio (Price-to-Earnings Ratio): Represents the price of the stock relative to its earnings per share. A higher P/E ratio indicates that investors are willing to pay a higher price for the stock.
  • Return on Equity (ROE): Measures a company's profitability relative to its shareholder equity. It showcases the company's ability to generate profits using the investment made by its shareholders, offering valuable insight into its operational efficiency and financial performance.
  • Book Value: Represents the net asset value of the company per share. It is calculated as the total assets minus intangible assets and liabilities, divided by the number of outstanding shares.
  • Dividend Yield: The ratio of the annual dividend per share to the current market price per share. It offers valuable insights into the profitability of an investment through dividends.
  • EPS CAGR (Compound Annual Growth Rate): Represents the geometric mean growth rate of earnings per share over the last 5 years. It provides insight into the historical growth trajectory of the company's earnings.

This formula allows us to gauge the intrinsic value of the stock by analyzing its fundamental indicators along with EPS growth.

As of November 22, 2024, Procter & Gamble Hygiene and Health Care Ltd is Undervalued by 2.13% compared to the current share price 15,876.00

Last 5 Year EPS CAGR: 11.47%

*Investments are subject to market risks

Strength and Weakness

StrengthWeakness
  1. The stock has a high average ROCE of 73.58%, which is a positive sign.
  2. The stock has a low average Working Capital Days of -10.17, which is a positive sign.
  3. The stock has a low average Cash Conversion Cycle of -85.67, which is a positive sign.
  4. The company has higher reserves (905.83 cr) compared to borrowings (1.25 cr), indicating strong financial stability.
  5. The company has shown consistent growth in sales (2.31 cr) and profit (543.15 cr) over the years.

    Stock Analysis

    • Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Procter & Gamble Hygiene and Health Care Ltd:
      1. Net Profit Margin: 17.3%
        • Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
      2. ROCE: 80.85% (Industry Average ROCE: 36.77%)
        • ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
      3. ROE%: 71.68% (Industry Average ROE: 29.68%)
        • ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
      4. Interest Coverage Ratio (Post Tax): 60.59
        • Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
      5. Quick Ratio: 1.18
        • Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
      6. Stock P/E: 76.2 (Industry average Stock P/E: 53.02)
        • Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
      7. Total Debt / Equity: 0
        • Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
      The current analysis is available for review. It's important to conduct thorough research and consider consulting with financial professionals before making any investment decisions.
      Stock Rating:

    About the Company - Qualitative Analysis

    Procter & Gamble Hygiene & Healthcare Ltd. is a Public Limited Listed company incorporated on 20/07/1964 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1964PLC012971 and registration number is 012971. Currently Company is involved in the business activities of Manufacture of `ayurvedic’ or `unani’ pharmaceutical preparation. Company’s Total Operating Revenue is Rs. 3900.92 Cr. and Equity Capital is Rs. 32.46 Cr. for the Year ended 30/06/2022.
    INDUSTRYADDRESSCONTACT
    Personal CareP & G Plaza, Cardinal Gracias Road, Mumbai Maharashtra 400099investorpghh.im@pg.com
    http://www.pg.com
    Management
    NamePosition Held
    Mr. Chittranjan DuaChairman & Ind.Director
    Mr. L V VaidyanathanManaging Director
    Mr. Krishnamurthy IyerIndependent Director
    Ms. Meena GaneshIndependent Director
    Mr. Anil Kumar GuptaIndependent Director
    Mr. Gurcharan DasIndependent Director
    Mr. Karthik NatarajanNon Executive Director
    Ms. Sonali DhawanNon Executive Director
    Mr. Gagan SawhneyNon Executive Director
    Mr. Pramod AgarwalNon Executive Director
    Mr. Ghanashyam HegdeExecutive Director

    FAQ

    What is the latest intrinsic value of Procter & Gamble Hygiene and Health Care Ltd?

    The latest intrinsic value of Procter & Gamble Hygiene and Health Care Ltd as on 21 November 2024 is ₹14545.85, which is 8.38% lower than the current market price of ₹15,876.00.

    What is the Market Cap of Procter & Gamble Hygiene and Health Care Ltd?

    The Market Cap of Procter & Gamble Hygiene and Health Care Ltd is 51,525 Cr..

    What is the current Stock Price of Procter & Gamble Hygiene and Health Care Ltd as on 21 November 2024?

    The current stock price of Procter & Gamble Hygiene and Health Care Ltd as on 21 November 2024 is ₹15,876.

    What is the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks in FY 2024?

    In FY 2024, the High / Low of Procter & Gamble Hygiene and Health Care Ltd stocks is 18,250/15,306.

    What is the Stock P/E of Procter & Gamble Hygiene and Health Care Ltd?

    The Stock P/E of Procter & Gamble Hygiene and Health Care Ltd is 76.2.

    What is the Book Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Book Value of Procter & Gamble Hygiene and Health Care Ltd is 239.

    What is the Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd?

    The Dividend Yield of Procter & Gamble Hygiene and Health Care Ltd is 1.23 %.

    What is the ROCE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROCE of Procter & Gamble Hygiene and Health Care Ltd is 112 %.

    What is the ROE of Procter & Gamble Hygiene and Health Care Ltd?

    The ROE of Procter & Gamble Hygiene and Health Care Ltd is 78.9 %.

    What is the Face Value of Procter & Gamble Hygiene and Health Care Ltd?

    The Face Value of Procter & Gamble Hygiene and Health Care Ltd is 10.0.

    About the Author

    Author Avatar
    Getaka

    Getaka, CFA, a financial analyst with 15 years of experience in the industry. Getaka holds an MBA degree and the Chartered Financial Analyst designation, demonstrating his profound understanding of financial analysis and investment management. Throughout his career, he has conducted numerous financial analyses and due diligence processes for companies in the industry, and has a strong track record of identifying key trends and opportunities. He leverages his expertise to deliver a thorough financial analysis of a company, encompassing its financial performance, key ratios, future prospects, and risks. Getaka is committed to providing accurate, reliable, and trustworthy information to help readers make informed decisions about their finances and investments.

    Disclaimer: This article is for informational purposes only and should not be construed as financial advice. The author is not a SEBI registered financial advisor and does not have any vested interest in Procter & Gamble Hygiene and Health Care Ltd. Investors are advised to conduct their own due diligence and consult with a financial professional before making any investment decisions. The information provided in this article is based on publicly available data and the author's analysis, but it may not be comprehensive or up-to-date. The author and getaka.co.in are not responsible for any errors or omissions in the content. This article is not intended to promote any particular investment strategy or recommendation, and readers should consult with their own financial advisors before making any investment decisions. Data Source: NSE